|
2008 Conference Publication Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron storesWilliams, E.J., Dixon, J., Powell, L.W. and Macdonald, G.A. (2008). Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April 2008. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(08)60984-8 |
|
2008 Conference Publication Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver diseaseHickman, I. J., Sullivan, C. M., Flight, S., Campbell, C., Crawford, D. H., Masci, P. P., O'Moore-Sullivan, T. M., Prins, J. B. and Macdonald, G. A. (2008). Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease. 16th European Congress on Obesity, Geneva, Switzerland, 14-17 May 2008. LONDON: NATURE PUBLISHING GROUP. |
|
2008 Conference Publication The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver diseaseNguyen, Thien, Murphy, Therese L., Lipka, Geraldine, Fletcher, Linda M. and Macdonald, Graeme A. (2008). The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, United States, 31 October-4 November 2008. Hoboken, NJ, United States: Wiley Interscience. doi: 10.1002/hep.22645 |
|
2008 Book Chapter Suspected iron overload or high serum ferritinMacdonald, Graeme A. (2008). Suspected iron overload or high serum ferritin. Gastroenterology and Hepatology: A clinical handbook. (pp. 389-396) edited by Nicholas J. Talley, Isidor Segal and Martin D. Weltman. Marrickville, N.S.W.: Elsevier Australia. |
|
2007 Journal Article Is vitamin E beneficial in chronic liver disease?Hickman, Ingrid J. and Macdonald, Graeme A. (2007). Is vitamin E beneficial in chronic liver disease?. Hepatology, 46 (2), 288-290. doi: 10.1002/hep.21834 |
|
2007 Journal Article Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetesHickman, Ingrid J., Whitehead, Jonathan P., Prins, Johannes B. and Macdonald, Graeme A. (2007). Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 9 (3), 438-440. doi: 10.1111/j.1463-1326.2006.00604.x |
|
2007 Journal Article Erratum: Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (British Journal of Cancer (2006) 95, (853-861) DOI: 10.1038/6603325)Cebon, J., Findlay, M., Hargreaves, C., Stockler, M., Thompson, P., Boyer, M., Roberts, S., Poon, A., Scott, A. M., Kalff, V., Garas, G., Dowling, A., Crawford, D., Ring, J., Basser, R., Strickland, A., MacDonald, G., Green, M., Nowak, A., Dickman, B., Dhillon, H. and Gebski, V. (2007). Erratum: Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (British Journal of Cancer (2006) 95, (853-861) DOI: 10.1038/6603325). British Journal of Cancer, 96 (7), 1154-1154. doi: 10.1038/sj.bjc.6603674 |
|
2007 Journal Article Impact of diabetes on the severity of liver diseaseHickman, I.J. and Macdonald, G.A. (2007). Impact of diabetes on the severity of liver disease. The American Journal of Medicine, 120 (10), 829-834. doi: 10.1016/j.amjmed.2007.03.025 |
|
2007 Journal Article Why do we not yet have combination chemotherapy for chronic hepatitis B?Sasadeusz, J. J., Locarnini, S. L. and Macdonald, G. (2007). Why do we not yet have combination chemotherapy for chronic hepatitis B?. Medical Journal of Australia, 186 (4), 204-206. doi: 10.5694/j.1326-5377.2007.tb00863.x |
|
2007 Conference Publication The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic studySharman, J. E., Holland, D., Kostner, K., Fairweather, H., Macdonald G. and Marwick T. H. (2007). The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study. Cardiac Society of Aust and NZ Annual Scientific Meeting, Christchurch, New Zealand, 9-12 August, 2007. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1016/j.hlc.2007.06.420 |
|
2007 Journal Article Silencing of O-6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South AfricaHerath, Nirmitha I., Walsh, Michael D., Kew, Michael, Smith, Jeffery L., Jass, Jeremy R., Young, Joanne, Leggett, Barbara A. and Macdonald, Graeme A. (2007). Silencing of O-6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa. Oncology Reports, 17 (4), 817-822. doi: 10.3892/or.17.4.817 |
|
2007 Conference Publication The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic studySharman, J., Holland, D., Kostner, K. M., Fairweather, H., Macdonald, G. A. and Marwick, T. H. (2007). The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study. European Society of Cardiology Annual Scientific Meeting, Vienna, Austria, 1-5 September, 2007. London ; New York: Oxford University Press. |
|
2006 Journal Article Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotideCebon, J., Australasian Gastro-Intestinal Trials Group (AGITG) AG0001H Investigators, Findlay, M., Hargreaves, C., Stockler, M., Thompson, P., Boyer, M., Roberts, S., Poon, A., Scott, A. M., Kalff, V., Garas, G., Dowling, A., Crawford, D., Ring, J., Basser, R., Strickland, A., Macdonald, G., Green, M., Nowak, A., Dickman, B., Dhillon, H. and Gebski, V. (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95 (7), 853-861. doi: 10.1038/sj.bjc.6603325 |
|
2006 Conference Publication The effect of steatosis on iron homeostasis in HuH-7 hepatoma cellsBeaton, M. D., Wilkins, S. J., Frazer, D. M., Whitehead, J. P., Moffitt, J. H., Macdonald, G. A., Powell, L. W. and Anderson, G. J. (2006). The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2006 Conference Publication Causes of raised liver enzymes in a diabetic clinicHickman, I. J., Russell, A. W. and Macdonald, G. A. (2006). Causes of raised liver enzymes in a diabetic clinic. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2006 Journal Article Living with chronic hepatitis C means 'you just haven't got a normal life any more'Conrad, S., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006). Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Chronic Illness, 2 (2), 121-131. doi: 10.1177/17423953060020020701 |
|
2006 Journal Article Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophreniaRichards, A. A., Hickman, I. J., Wang, A. Y. H., Jones, A. L., Newell, F., Mowry, B. J., Whitehead, J. P., Prins, J. B. and Macdonald, G. A. (2006). Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophrenia. Journal of Clinical Psychopharmacology, 26 (3), 232-237. doi: 10.1097/01.jcp.0000218404.64619.52 |
|
2006 Journal Article Adiponectin – a key adipokine in the metabolic syndromeWhitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald , G. A. and Prins, J. B. (2006). Adiponectin – a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism, 8 (3), 264-280. doi: 10.1111/j.1463-1326.2005.00510.x |
|
2006 Journal Article Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infectionLang, C. A., Conrad, S., Garrett, L., Battistutta, D., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006). Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. Journal of Pain And Symptom Management, 31 (4), 335-344. doi: 10.1016/j.jpainsymman.2005.08.016 |
|
2006 Conference Publication Serum adiponectin is increased in HFE-/- mice fed alcoholBridle, K. R., Murphy, T. L., Anderson, G. J., Macdonald, G. A., Crawford, D. H. G. and Fletcher, L. M. (2006). Serum adiponectin is increased in HFE-/- mice fed alcohol. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
